Global Biologics CMO (Contract Manufacturing Organization) Services Supply, Demand and Key Producers, 2026-2032
The global Biologics CMO (Contract Manufacturing Organization) Services market size is expected to reach $ 50955 million by 2032, rising at a market growth of 8.5% CAGR during the forecast period (2026-2032).
Biologics CMO (Contract Manufacturing Organization) Services refer to manufacturing services provided by contract manufacturing organizations under client agreements to biopharmaceutical companies, pharmaceutical companies, and other drug development organizations. These services primarily include biologic drug substance manufacturing, drug product manufacturing, aseptic fill-finish, and other GMP manufacturing activities. The service scope covers antibodies, vaccines, cell and gene therapies, and other biologics, and may support both clinical-stage and commercial-stage production. The market includes contract manufacturing services provided by independent third-party CMOs as well as external manufacturing services offered by in-house CMO business units of pharmaceutical and biopharmaceutical companies. Compared with CDMO services, CMO services are primarily focused on manufacturing execution and production capabilities and generally do not emphasize early-stage drug development, comprehensive process development, formulation development, or other R&D-intensive activities.
Biologics CMO (Contract Manufacturing Organization) services refer to GMP manufacturing services provided under contract to pharmaceutical companies, biotechnology companies, and other drug development organizations. These services primarily cover biologic drug substance (DS) manufacturing, drug product (DP) manufacturing, aseptic fill-finish, packaging, and related quality control activities. By provider type, the industry includes both independent CMOs whose core business is third-party contract manufacturing and in-house CMO business units of large pharmaceutical and biopharmaceutical companies that provide manufacturing capacity to external customers. Compared with CDMOs, CMOs place greater emphasis on process execution following technology transfer, scale-up manufacturing, quality control, and reliable supply, while early-stage drug discovery, systematic process development, and formulation development are generally not their primary functions.
By product type, biologics CMO services mainly cover antibodies, vaccines, cell and gene therapies, and other biologics. Antibodies represent one of the more mature contract manufacturing segments and typically involve mammalian cell culture, harvest, chromatography purification, viral clearance, and drug substance preparation. Vaccine manufacturing involves a wider range of production platforms and process technologies. Cell and gene therapies generally feature smaller batch sizes, more complex processes, stringent quality requirements, and highly customized manufacturing workflows. Consequently, facility design, equipment configuration, biosafety requirements, and quality systems vary significantly across different biologic modalities.
By manufacturing stage, the industry can be divided into biologic drug substance manufacturing and biologic drug product manufacturing. Drug substance manufacturing is generally the more technology- and capital-intensive segment and includes cell culture or microbial fermentation, separation, purification, and bulk drug substance storage. Drug product manufacturing primarily covers formulation, aseptic filling, lyophilization, and filling into vials, prefilled syringes, or cartridges. Some large CMOs have established integrated DS-to-DP manufacturing networks, while other specialized providers focus on large-scale drug substance manufacturing or specific activities such as sterile fill-finish.
Direct customers primarily include large pharmaceutical and biopharmaceutical companies, small and mid-sized pharmaceutical and biotechnology companies, and other drug development organizations. Large pharmaceutical companies generally maintain internal manufacturing capabilities but may outsource production due to capacity constraints, new product introductions, regional supply requirements, specialized manufacturing needs, or efforts to reduce fixed-asset investment. Small and mid-sized biotechnology companies tend to rely more heavily on external manufacturing resources, with CMOs supporting clinical supply, scale-up, and commercial production.
Biologics CMO is an industry characterized by high capital, technical, and regulatory barriers. Mammalian cell culture is a core platform for antibodies and many recombinant proteins. Commercial manufacturing commonly utilizes individual bioreactors ranging from approximately 2,000 L to 20,000 L, while large-scale commercial facilities typically combine multiple bioreactors into a production train. Effective annual capacity per production line depends on the number of bioreactors, culture cycle, product titer, batch success rate, and facility utilization. Single-use bioreactors offer shorter construction timelines, greater flexibility for product changeover, and lower cross-contamination risk, while large stainless-steel systems continue to provide significant economies of scale for mature, high-volume commercial products.
The upstream supply chain primarily consists of cell culture media, single-use bioprocess consumables, bioreactors, filtration systems, chromatography resins and columns, buffer materials, and sterile packaging components. Critical materials such as culture media, single-use consumables, and high-performance chromatography media can materially affect batch consistency and product quality. Major CMOs therefore typically establish multi-supplier strategies and safety stocks for critical materials while increasing facility utilization through standardized platform processes.
Regulatory compliance and quality systems constitute major competitive barriers. Biologics manufacturing must continuously comply with GMP requirements and maintain robust systems for quality management, data integrity, contamination control, process validation, and batch release. Once a commercial product has received regulatory approval and its manufacturing process has been validated at a specific CMO facility, transferring production to another site generally requires additional technology transfer, validation, and regulatory change procedures. The associated time and cost create relatively high customer stickiness and long contract durations for established commercial products.
Key competitive factors include commercial manufacturing experience, GMP compliance track record, manufacturing scale, capacity utilization, technology transfer efficiency, batch success rates, delivery reliability, and global manufacturing networks. Large CMOs with extensive bioreactor capacity and multiple manufacturing sites are well positioned to serve high-volume commercial antibody products, while mid-sized and specialized CMOs differentiate themselves through flexible capacity, small-batch manufacturing, complex molecule capabilities, or specialized technology platforms.
Profitability varies significantly depending on product type, manufacturing scale, capacity utilization, and development stage. Mature commercial biologics generally provide more stable batch demand and higher equipment utilization, whereas clinical-stage projects involve smaller batch volumes, frequent product changeovers, and greater project attrition. Gross margins for established biologics CMO manufacturing operations can generally fall within approximately 20%–40%. Large-scale antibody drug substance manufacturing can achieve stronger economies of scale at high utilization rates, while cell and gene therapy manufacturing and small-batch sterile fill-finish may command higher unit pricing but also require greater labor, quality control, and facility costs.
Future industry growth will be supported by the continued expansion of biologics pipelines, increasing commercialization of antibody drugs and emerging biologic modalities, efforts by pharmaceutical companies to reduce fixed-asset investment, and deeper specialization across pharmaceutical manufacturing networks. At the same time, major CMOs continue to add large-scale 20,000 L-class mammalian cell culture capacity, resulting in greater capacity availability in certain regions. Competition is therefore expected to gradually shift from pure capacity expansion toward a broader focus on capacity utilization, manufacturing efficiency, quality consistency, supply reliability, and lifecycle manufacturing capabilities.
This report is a detailed and comprehensive analysis of the world market for Biologics CMO (Contract Manufacturing Organization) Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics CMO (Contract Manufacturing Organization) Services that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biologics CMO (Contract Manufacturing Organization) Services market
2. What is the demand of the global Biologics CMO (Contract Manufacturing Organization) Services market?
3. What is the year over year growth of the global Biologics CMO (Contract Manufacturing Organization) Services market?
4. What is the total value of the global Biologics CMO (Contract Manufacturing Organization) Services market?
5. Who are the Major Players in the global Biologics CMO (Contract Manufacturing Organization) Services market?
6. What are the growth factors driving the market demand?
Biologics CMO (Contract Manufacturing Organization) Services refer to manufacturing services provided by contract manufacturing organizations under client agreements to biopharmaceutical companies, pharmaceutical companies, and other drug development organizations. These services primarily include biologic drug substance manufacturing, drug product manufacturing, aseptic fill-finish, and other GMP manufacturing activities. The service scope covers antibodies, vaccines, cell and gene therapies, and other biologics, and may support both clinical-stage and commercial-stage production. The market includes contract manufacturing services provided by independent third-party CMOs as well as external manufacturing services offered by in-house CMO business units of pharmaceutical and biopharmaceutical companies. Compared with CDMO services, CMO services are primarily focused on manufacturing execution and production capabilities and generally do not emphasize early-stage drug development, comprehensive process development, formulation development, or other R&D-intensive activities.
Biologics CMO (Contract Manufacturing Organization) services refer to GMP manufacturing services provided under contract to pharmaceutical companies, biotechnology companies, and other drug development organizations. These services primarily cover biologic drug substance (DS) manufacturing, drug product (DP) manufacturing, aseptic fill-finish, packaging, and related quality control activities. By provider type, the industry includes both independent CMOs whose core business is third-party contract manufacturing and in-house CMO business units of large pharmaceutical and biopharmaceutical companies that provide manufacturing capacity to external customers. Compared with CDMOs, CMOs place greater emphasis on process execution following technology transfer, scale-up manufacturing, quality control, and reliable supply, while early-stage drug discovery, systematic process development, and formulation development are generally not their primary functions.
By product type, biologics CMO services mainly cover antibodies, vaccines, cell and gene therapies, and other biologics. Antibodies represent one of the more mature contract manufacturing segments and typically involve mammalian cell culture, harvest, chromatography purification, viral clearance, and drug substance preparation. Vaccine manufacturing involves a wider range of production platforms and process technologies. Cell and gene therapies generally feature smaller batch sizes, more complex processes, stringent quality requirements, and highly customized manufacturing workflows. Consequently, facility design, equipment configuration, biosafety requirements, and quality systems vary significantly across different biologic modalities.
By manufacturing stage, the industry can be divided into biologic drug substance manufacturing and biologic drug product manufacturing. Drug substance manufacturing is generally the more technology- and capital-intensive segment and includes cell culture or microbial fermentation, separation, purification, and bulk drug substance storage. Drug product manufacturing primarily covers formulation, aseptic filling, lyophilization, and filling into vials, prefilled syringes, or cartridges. Some large CMOs have established integrated DS-to-DP manufacturing networks, while other specialized providers focus on large-scale drug substance manufacturing or specific activities such as sterile fill-finish.
Direct customers primarily include large pharmaceutical and biopharmaceutical companies, small and mid-sized pharmaceutical and biotechnology companies, and other drug development organizations. Large pharmaceutical companies generally maintain internal manufacturing capabilities but may outsource production due to capacity constraints, new product introductions, regional supply requirements, specialized manufacturing needs, or efforts to reduce fixed-asset investment. Small and mid-sized biotechnology companies tend to rely more heavily on external manufacturing resources, with CMOs supporting clinical supply, scale-up, and commercial production.
Biologics CMO is an industry characterized by high capital, technical, and regulatory barriers. Mammalian cell culture is a core platform for antibodies and many recombinant proteins. Commercial manufacturing commonly utilizes individual bioreactors ranging from approximately 2,000 L to 20,000 L, while large-scale commercial facilities typically combine multiple bioreactors into a production train. Effective annual capacity per production line depends on the number of bioreactors, culture cycle, product titer, batch success rate, and facility utilization. Single-use bioreactors offer shorter construction timelines, greater flexibility for product changeover, and lower cross-contamination risk, while large stainless-steel systems continue to provide significant economies of scale for mature, high-volume commercial products.
The upstream supply chain primarily consists of cell culture media, single-use bioprocess consumables, bioreactors, filtration systems, chromatography resins and columns, buffer materials, and sterile packaging components. Critical materials such as culture media, single-use consumables, and high-performance chromatography media can materially affect batch consistency and product quality. Major CMOs therefore typically establish multi-supplier strategies and safety stocks for critical materials while increasing facility utilization through standardized platform processes.
Regulatory compliance and quality systems constitute major competitive barriers. Biologics manufacturing must continuously comply with GMP requirements and maintain robust systems for quality management, data integrity, contamination control, process validation, and batch release. Once a commercial product has received regulatory approval and its manufacturing process has been validated at a specific CMO facility, transferring production to another site generally requires additional technology transfer, validation, and regulatory change procedures. The associated time and cost create relatively high customer stickiness and long contract durations for established commercial products.
Key competitive factors include commercial manufacturing experience, GMP compliance track record, manufacturing scale, capacity utilization, technology transfer efficiency, batch success rates, delivery reliability, and global manufacturing networks. Large CMOs with extensive bioreactor capacity and multiple manufacturing sites are well positioned to serve high-volume commercial antibody products, while mid-sized and specialized CMOs differentiate themselves through flexible capacity, small-batch manufacturing, complex molecule capabilities, or specialized technology platforms.
Profitability varies significantly depending on product type, manufacturing scale, capacity utilization, and development stage. Mature commercial biologics generally provide more stable batch demand and higher equipment utilization, whereas clinical-stage projects involve smaller batch volumes, frequent product changeovers, and greater project attrition. Gross margins for established biologics CMO manufacturing operations can generally fall within approximately 20%–40%. Large-scale antibody drug substance manufacturing can achieve stronger economies of scale at high utilization rates, while cell and gene therapy manufacturing and small-batch sterile fill-finish may command higher unit pricing but also require greater labor, quality control, and facility costs.
Future industry growth will be supported by the continued expansion of biologics pipelines, increasing commercialization of antibody drugs and emerging biologic modalities, efforts by pharmaceutical companies to reduce fixed-asset investment, and deeper specialization across pharmaceutical manufacturing networks. At the same time, major CMOs continue to add large-scale 20,000 L-class mammalian cell culture capacity, resulting in greater capacity availability in certain regions. Competition is therefore expected to gradually shift from pure capacity expansion toward a broader focus on capacity utilization, manufacturing efficiency, quality consistency, supply reliability, and lifecycle manufacturing capabilities.
Report Scope
This report studies the global Biologics CMO (Contract Manufacturing Organization) Services demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Biologics CMO (Contract Manufacturing Organization) Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics CMO (Contract Manufacturing Organization) Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Biologics CMO (Contract Manufacturing Organization) Services total market, 2021-2032, (USD Million)
- Global Biologics CMO (Contract Manufacturing Organization) Services total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Biologics CMO (Contract Manufacturing Organization) Services total market, key domestic companies, and share, (USD Million)
- Global Biologics CMO (Contract Manufacturing Organization) Services revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Biologics CMO (Contract Manufacturing Organization) Services total market by Type, CAGR, 2021-2032, (USD Million)
- Global Biologics CMO (Contract Manufacturing Organization) Services total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biologics CMO (Contract Manufacturing Organization) Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Biologics CMO (Contract Manufacturing Organization) Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Biologics CMO (Contract Manufacturing Organization) Services Market, Segmentation by Type:
- Cell and Gene Therapies
- Antibodies
- Vaccines
- Others
Global Biologics CMO (Contract Manufacturing Organization) Services Market, Segmentation by CMO Provider Type:
- In-house CMO
- Independent CMO
Global Biologics CMO (Contract Manufacturing Organization) Services Market, Segmentation by Manufacturing Stage:
- Drug Substance (DS) Manufacturing
- Drug Product (DP) Manufacturing
Global Biologics CMO (Contract Manufacturing Organization) Services Market, Segmentation by Application:
- Large Pharmaceutical and Biopharmaceutical Companies
- Small and Mid-sized Pharmaceutical and Biotechnology Companies
- Others
Companies Profiled:
- Lonza Group AG
- Samsung Biologics Co., Ltd.
- FUJIFILM Biotechnologies
- Boehringer Ingelheim BioXcellence
- WuXi Biologics (Cayman) Inc.
- Thermo Fisher Scientific – Patheon Pharma Services
- Catalent, Inc.
- AGC Biologics
- National Resilience, Inc.
- Vetter Pharma International GmbH
- Rentschler Biopharma SE
- KBI Biopharma, Inc.
- LOTTE BIOLOGICS Co., Ltd.
- Pfizer CentreOne
- AbbVie Contract Manufacturing
- Syngene International Limited
- Avid Bioservices, Inc.
- Recipharm Advanced Bio
- Ajinomoto Bio-Pharma Services
- Wacker Biotech GmbH
- Bora Biologics
- 3PBIOVIAN
- Fareva
- Aenova Group
- Siegfried Holding AG
- GenScript ProBio
- Chime Biologics (Wuhan) Co., Ltd.
- MabPlex International
- Pharmaron Beijing Co., Ltd.
- Thousand Oaks Biologics Inc.
- Cytovance Biologics, Inc.
- Porton Pharma Solutions Ltd.
Key Questions Answered
1. How big is the global Biologics CMO (Contract Manufacturing Organization) Services market?2. What is the demand of the global Biologics CMO (Contract Manufacturing Organization) Services market?
3. What is the year over year growth of the global Biologics CMO (Contract Manufacturing Organization) Services market?
4. What is the total value of the global Biologics CMO (Contract Manufacturing Organization) Services market?
5. Who are the Major Players in the global Biologics CMO (Contract Manufacturing Organization) Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biologics CMO (Contract Manufacturing Organization) Services Introduction
1.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Biologics CMO (Contract Manufacturing Organization) Services Total Market by Region (by Headquarter Location)
1.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.3 China Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.4 Europe Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.5 Japan Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.6 South Korea Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.8 India Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biologics CMO (Contract Manufacturing Organization) Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.2 World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region
2.2.1 World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2026)
2.2.2 World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.4 China Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.5 Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.6 Japan Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.7 South Korea Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.8 ASEAN Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.9 India Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
3 WORLD BIOLOGICS CMO (CONTRACT MANUFACTURING ORGANIZATION) SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biologics CMO (Contract Manufacturing Organization) Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biologics CMO (Contract Manufacturing Organization) Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Biologics CMO (Contract Manufacturing Organization) Services in 2025
3.3 Biologics CMO (Contract Manufacturing Organization) Services Company Evaluation Quadrant
3.4 Biologics CMO (Contract Manufacturing Organization) Services Market: Overall Company Footprint Analysis
3.4.1 Biologics CMO (Contract Manufacturing Organization) Services Market: Region Footprint
3.4.2 Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Type Footprint
3.4.3 Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Comparison
4.2.1 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Biologics CMO (Contract Manufacturing Organization) Services Companies and Market Share, 2021-2026
4.3.1 United States Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue, (2021-2026)
4.4 China Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue and Market Share, 2021-2026
4.4.1 China Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue, (2021-2026)
4.5 Rest of World Based Biologics CMO (Contract Manufacturing Organization) Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cell and Gene Therapies
5.2.2 Antibodies
5.2.3 Vaccines
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026)
5.3.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2027-2032)
5.3.3 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CMO PROVIDER TYPE
6.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Overview by CMO Provider Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by CMO Provider Type
6.2.1 In-house CMO
6.2.2 Independent CMO
6.3 Market Segment by CMO Provider Type
6.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type (2021-2026)
6.3.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type (2027-2032)
6.3.3 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type (2027-2032)
7 MARKET ANALYSIS BY MANUFACTURING STAGE
7.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Overview by Manufacturing Stage: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Manufacturing Stage
7.2.1 Drug Substance (DS) Manufacturing
7.2.2 Drug Product (DP) Manufacturing
7.3 Market Segment by Manufacturing Stage
7.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage (2021-2026)
7.3.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage (2027-2032)
7.3.3 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large Pharmaceutical and Biopharmaceutical Companies
8.2.2 Small and Mid-sized Pharmaceutical and Biotechnology Companies
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026)
8.3.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2027-2032)
8.3.3 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lonza Group AG
9.1.1 Lonza Group AG Details
9.1.2 Lonza Group AG Major Business
9.1.3 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.1.4 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Lonza Group AG Recent Developments/Updates
9.1.6 Lonza Group AG Competitive Strengths & Weaknesses
9.2 Samsung Biologics Co., Ltd.
9.2.1 Samsung Biologics Co., Ltd. Details
9.2.2 Samsung Biologics Co., Ltd. Major Business
9.2.3 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.2.4 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Samsung Biologics Co., Ltd. Recent Developments/Updates
9.2.6 Samsung Biologics Co., Ltd. Competitive Strengths & Weaknesses
9.3 FUJIFILM Biotechnologies
9.3.1 FUJIFILM Biotechnologies Details
9.3.2 FUJIFILM Biotechnologies Major Business
9.3.3 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.3.4 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 FUJIFILM Biotechnologies Recent Developments/Updates
9.3.6 FUJIFILM Biotechnologies Competitive Strengths & Weaknesses
9.4 Boehringer Ingelheim BioXcellence
9.4.1 Boehringer Ingelheim BioXcellence Details
9.4.2 Boehringer Ingelheim BioXcellence Major Business
9.4.3 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.4.4 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Boehringer Ingelheim BioXcellence Recent Developments/Updates
9.4.6 Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
9.5 WuXi Biologics (Cayman) Inc.
9.5.1 WuXi Biologics (Cayman) Inc. Details
9.5.2 WuXi Biologics (Cayman) Inc. Major Business
9.5.3 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.5.4 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 WuXi Biologics (Cayman) Inc. Recent Developments/Updates
9.5.6 WuXi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
9.6 Thermo Fisher Scientific – Patheon Pharma Services
9.6.1 Thermo Fisher Scientific – Patheon Pharma Services Details
9.6.2 Thermo Fisher Scientific – Patheon Pharma Services Major Business
9.6.3 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.6.4 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Thermo Fisher Scientific – Patheon Pharma Services Recent Developments/Updates
9.6.6 Thermo Fisher Scientific – Patheon Pharma Services Competitive Strengths & Weaknesses
9.7 Catalent, Inc.
9.7.1 Catalent, Inc. Details
9.7.2 Catalent, Inc. Major Business
9.7.3 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.7.4 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent, Inc. Recent Developments/Updates
9.7.6 Catalent, Inc. Competitive Strengths & Weaknesses
9.8 AGC Biologics
9.8.1 AGC Biologics Details
9.8.2 AGC Biologics Major Business
9.8.3 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.8.4 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 AGC Biologics Recent Developments/Updates
9.8.6 AGC Biologics Competitive Strengths & Weaknesses
9.9 National Resilience, Inc.
9.9.1 National Resilience, Inc. Details
9.9.2 National Resilience, Inc. Major Business
9.9.3 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.9.4 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 National Resilience, Inc. Recent Developments/Updates
9.9.6 National Resilience, Inc. Competitive Strengths & Weaknesses
9.10 Vetter Pharma International GmbH
9.10.1 Vetter Pharma International GmbH Details
9.10.2 Vetter Pharma International GmbH Major Business
9.10.3 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.10.4 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Vetter Pharma International GmbH Recent Developments/Updates
9.10.6 Vetter Pharma International GmbH Competitive Strengths & Weaknesses
9.11 Rentschler Biopharma SE
9.11.1 Rentschler Biopharma SE Details
9.11.2 Rentschler Biopharma SE Major Business
9.11.3 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.11.4 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Rentschler Biopharma SE Recent Developments/Updates
9.11.6 Rentschler Biopharma SE Competitive Strengths & Weaknesses
9.12 KBI Biopharma, Inc.
9.12.1 KBI Biopharma, Inc. Details
9.12.2 KBI Biopharma, Inc. Major Business
9.12.3 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.12.4 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 KBI Biopharma, Inc. Recent Developments/Updates
9.12.6 KBI Biopharma, Inc. Competitive Strengths & Weaknesses
9.13 LOTTE BIOLOGICS Co., Ltd.
9.13.1 LOTTE BIOLOGICS Co., Ltd. Details
9.13.2 LOTTE BIOLOGICS Co., Ltd. Major Business
9.13.3 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.13.4 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 LOTTE BIOLOGICS Co., Ltd. Recent Developments/Updates
9.13.6 LOTTE BIOLOGICS Co., Ltd. Competitive Strengths & Weaknesses
9.14 Pfizer CentreOne
9.14.1 Pfizer CentreOne Details
9.14.2 Pfizer CentreOne Major Business
9.14.3 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.14.4 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Pfizer CentreOne Recent Developments/Updates
9.14.6 Pfizer CentreOne Competitive Strengths & Weaknesses
9.15 AbbVie Contract Manufacturing
9.15.1 AbbVie Contract Manufacturing Details
9.15.2 AbbVie Contract Manufacturing Major Business
9.15.3 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.15.4 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 AbbVie Contract Manufacturing Recent Developments/Updates
9.15.6 AbbVie Contract Manufacturing Competitive Strengths & Weaknesses
9.16 Syngene International Limited
9.16.1 Syngene International Limited Details
9.16.2 Syngene International Limited Major Business
9.16.3 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.16.4 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Syngene International Limited Recent Developments/Updates
9.16.6 Syngene International Limited Competitive Strengths & Weaknesses
9.17 Avid Bioservices, Inc.
9.17.1 Avid Bioservices, Inc. Details
9.17.2 Avid Bioservices, Inc. Major Business
9.17.3 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.17.4 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Avid Bioservices, Inc. Recent Developments/Updates
9.17.6 Avid Bioservices, Inc. Competitive Strengths & Weaknesses
9.18 Recipharm Advanced Bio
9.18.1 Recipharm Advanced Bio Details
9.18.2 Recipharm Advanced Bio Major Business
9.18.3 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.18.4 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Recipharm Advanced Bio Recent Developments/Updates
9.18.6 Recipharm Advanced Bio Competitive Strengths & Weaknesses
9.19 Ajinomoto Bio-Pharma Services
9.19.1 Ajinomoto Bio-Pharma Services Details
9.19.2 Ajinomoto Bio-Pharma Services Major Business
9.19.3 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.19.4 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Ajinomoto Bio-Pharma Services Recent Developments/Updates
9.19.6 Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
9.20 Wacker Biotech GmbH
9.20.1 Wacker Biotech GmbH Details
9.20.2 Wacker Biotech GmbH Major Business
9.20.3 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.20.4 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Wacker Biotech GmbH Recent Developments/Updates
9.20.6 Wacker Biotech GmbH Competitive Strengths & Weaknesses
9.21 Bora Biologics
9.21.1 Bora Biologics Details
9.21.2 Bora Biologics Major Business
9.21.3 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.21.4 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Bora Biologics Recent Developments/Updates
9.21.6 Bora Biologics Competitive Strengths & Weaknesses
9.22 3PBIOVIAN
9.22.1 3PBIOVIAN Details
9.22.2 3PBIOVIAN Major Business
9.22.3 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.22.4 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 3PBIOVIAN Recent Developments/Updates
9.22.6 3PBIOVIAN Competitive Strengths & Weaknesses
9.23 Fareva
9.23.1 Fareva Details
9.23.2 Fareva Major Business
9.23.3 Fareva Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.23.4 Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Fareva Recent Developments/Updates
9.23.6 Fareva Competitive Strengths & Weaknesses
9.24 Aenova Group
9.24.1 Aenova Group Details
9.24.2 Aenova Group Major Business
9.24.3 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.24.4 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Aenova Group Recent Developments/Updates
9.24.6 Aenova Group Competitive Strengths & Weaknesses
9.25 Siegfried Holding AG
9.25.1 Siegfried Holding AG Details
9.25.2 Siegfried Holding AG Major Business
9.25.3 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.25.4 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Siegfried Holding AG Recent Developments/Updates
9.25.6 Siegfried Holding AG Competitive Strengths & Weaknesses
9.26 GenScript ProBio
9.26.1 GenScript ProBio Details
9.26.2 GenScript ProBio Major Business
9.26.3 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.26.4 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 GenScript ProBio Recent Developments/Updates
9.26.6 GenScript ProBio Competitive Strengths & Weaknesses
9.27 Chime Biologics (Wuhan) Co., Ltd.
9.27.1 Chime Biologics (Wuhan) Co., Ltd. Details
9.27.2 Chime Biologics (Wuhan) Co., Ltd. Major Business
9.27.3 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.27.4 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Chime Biologics (Wuhan) Co., Ltd. Recent Developments/Updates
9.27.6 Chime Biologics (Wuhan) Co., Ltd. Competitive Strengths & Weaknesses
9.28 MabPlex International
9.28.1 MabPlex International Details
9.28.2 MabPlex International Major Business
9.28.3 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.28.4 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 MabPlex International Recent Developments/Updates
9.28.6 MabPlex International Competitive Strengths & Weaknesses
9.29 Pharmaron Beijing Co., Ltd.
9.29.1 Pharmaron Beijing Co., Ltd. Details
9.29.2 Pharmaron Beijing Co., Ltd. Major Business
9.29.3 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.29.4 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Pharmaron Beijing Co., Ltd. Recent Developments/Updates
9.29.6 Pharmaron Beijing Co., Ltd. Competitive Strengths & Weaknesses
9.30 Thousand Oaks Biologics Inc.
9.30.1 Thousand Oaks Biologics Inc. Details
9.30.2 Thousand Oaks Biologics Inc. Major Business
9.30.3 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.30.4 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Thousand Oaks Biologics Inc. Recent Developments/Updates
9.30.6 Thousand Oaks Biologics Inc. Competitive Strengths & Weaknesses
9.31 Cytovance Biologics, Inc.
9.31.1 Cytovance Biologics, Inc. Details
9.31.2 Cytovance Biologics, Inc. Major Business
9.31.3 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.31.4 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Cytovance Biologics, Inc. Recent Developments/Updates
9.31.6 Cytovance Biologics, Inc. Competitive Strengths & Weaknesses
9.32 Porton Pharma Solutions Ltd.
9.32.1 Porton Pharma Solutions Ltd. Details
9.32.2 Porton Pharma Solutions Ltd. Major Business
9.32.3 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.32.4 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Porton Pharma Solutions Ltd. Recent Developments/Updates
9.32.6 Porton Pharma Solutions Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Biologics CMO (Contract Manufacturing Organization) Services Industry Chain
10.2 Biologics CMO (Contract Manufacturing Organization) Services Upstream Analysis
10.3 Biologics CMO (Contract Manufacturing Organization) Services Midstream Analysis
10.4 Biologics CMO (Contract Manufacturing Organization) Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Biologics CMO (Contract Manufacturing Organization) Services Introduction
1.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Biologics CMO (Contract Manufacturing Organization) Services Total Market by Region (by Headquarter Location)
1.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.3 China Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.4 Europe Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.5 Japan Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.6 South Korea Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.3.8 India Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biologics CMO (Contract Manufacturing Organization) Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.2 World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region
2.2.1 World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2026)
2.2.2 World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.4 China Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.5 Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.6 Japan Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.7 South Korea Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.8 ASEAN Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
2.9 India Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032)
3 WORLD BIOLOGICS CMO (CONTRACT MANUFACTURING ORGANIZATION) SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biologics CMO (Contract Manufacturing Organization) Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biologics CMO (Contract Manufacturing Organization) Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Biologics CMO (Contract Manufacturing Organization) Services in 2025
3.3 Biologics CMO (Contract Manufacturing Organization) Services Company Evaluation Quadrant
3.4 Biologics CMO (Contract Manufacturing Organization) Services Market: Overall Company Footprint Analysis
3.4.1 Biologics CMO (Contract Manufacturing Organization) Services Market: Region Footprint
3.4.2 Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Type Footprint
3.4.3 Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Comparison
4.2.1 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Biologics CMO (Contract Manufacturing Organization) Services Companies and Market Share, 2021-2026
4.3.1 United States Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue, (2021-2026)
4.4 China Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue and Market Share, 2021-2026
4.4.1 China Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue, (2021-2026)
4.5 Rest of World Based Biologics CMO (Contract Manufacturing Organization) Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cell and Gene Therapies
5.2.2 Antibodies
5.2.3 Vaccines
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026)
5.3.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2027-2032)
5.3.3 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CMO PROVIDER TYPE
6.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Overview by CMO Provider Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by CMO Provider Type
6.2.1 In-house CMO
6.2.2 Independent CMO
6.3 Market Segment by CMO Provider Type
6.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type (2021-2026)
6.3.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type (2027-2032)
6.3.3 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type (2027-2032)
7 MARKET ANALYSIS BY MANUFACTURING STAGE
7.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Overview by Manufacturing Stage: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Manufacturing Stage
7.2.1 Drug Substance (DS) Manufacturing
7.2.2 Drug Product (DP) Manufacturing
7.3 Market Segment by Manufacturing Stage
7.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage (2021-2026)
7.3.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage (2027-2032)
7.3.3 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large Pharmaceutical and Biopharmaceutical Companies
8.2.2 Small and Mid-sized Pharmaceutical and Biotechnology Companies
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026)
8.3.2 World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2027-2032)
8.3.3 World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lonza Group AG
9.1.1 Lonza Group AG Details
9.1.2 Lonza Group AG Major Business
9.1.3 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.1.4 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Lonza Group AG Recent Developments/Updates
9.1.6 Lonza Group AG Competitive Strengths & Weaknesses
9.2 Samsung Biologics Co., Ltd.
9.2.1 Samsung Biologics Co., Ltd. Details
9.2.2 Samsung Biologics Co., Ltd. Major Business
9.2.3 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.2.4 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Samsung Biologics Co., Ltd. Recent Developments/Updates
9.2.6 Samsung Biologics Co., Ltd. Competitive Strengths & Weaknesses
9.3 FUJIFILM Biotechnologies
9.3.1 FUJIFILM Biotechnologies Details
9.3.2 FUJIFILM Biotechnologies Major Business
9.3.3 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.3.4 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 FUJIFILM Biotechnologies Recent Developments/Updates
9.3.6 FUJIFILM Biotechnologies Competitive Strengths & Weaknesses
9.4 Boehringer Ingelheim BioXcellence
9.4.1 Boehringer Ingelheim BioXcellence Details
9.4.2 Boehringer Ingelheim BioXcellence Major Business
9.4.3 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.4.4 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Boehringer Ingelheim BioXcellence Recent Developments/Updates
9.4.6 Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
9.5 WuXi Biologics (Cayman) Inc.
9.5.1 WuXi Biologics (Cayman) Inc. Details
9.5.2 WuXi Biologics (Cayman) Inc. Major Business
9.5.3 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.5.4 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 WuXi Biologics (Cayman) Inc. Recent Developments/Updates
9.5.6 WuXi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
9.6 Thermo Fisher Scientific – Patheon Pharma Services
9.6.1 Thermo Fisher Scientific – Patheon Pharma Services Details
9.6.2 Thermo Fisher Scientific – Patheon Pharma Services Major Business
9.6.3 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.6.4 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Thermo Fisher Scientific – Patheon Pharma Services Recent Developments/Updates
9.6.6 Thermo Fisher Scientific – Patheon Pharma Services Competitive Strengths & Weaknesses
9.7 Catalent, Inc.
9.7.1 Catalent, Inc. Details
9.7.2 Catalent, Inc. Major Business
9.7.3 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.7.4 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent, Inc. Recent Developments/Updates
9.7.6 Catalent, Inc. Competitive Strengths & Weaknesses
9.8 AGC Biologics
9.8.1 AGC Biologics Details
9.8.2 AGC Biologics Major Business
9.8.3 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.8.4 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 AGC Biologics Recent Developments/Updates
9.8.6 AGC Biologics Competitive Strengths & Weaknesses
9.9 National Resilience, Inc.
9.9.1 National Resilience, Inc. Details
9.9.2 National Resilience, Inc. Major Business
9.9.3 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.9.4 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 National Resilience, Inc. Recent Developments/Updates
9.9.6 National Resilience, Inc. Competitive Strengths & Weaknesses
9.10 Vetter Pharma International GmbH
9.10.1 Vetter Pharma International GmbH Details
9.10.2 Vetter Pharma International GmbH Major Business
9.10.3 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.10.4 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Vetter Pharma International GmbH Recent Developments/Updates
9.10.6 Vetter Pharma International GmbH Competitive Strengths & Weaknesses
9.11 Rentschler Biopharma SE
9.11.1 Rentschler Biopharma SE Details
9.11.2 Rentschler Biopharma SE Major Business
9.11.3 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.11.4 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Rentschler Biopharma SE Recent Developments/Updates
9.11.6 Rentschler Biopharma SE Competitive Strengths & Weaknesses
9.12 KBI Biopharma, Inc.
9.12.1 KBI Biopharma, Inc. Details
9.12.2 KBI Biopharma, Inc. Major Business
9.12.3 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.12.4 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 KBI Biopharma, Inc. Recent Developments/Updates
9.12.6 KBI Biopharma, Inc. Competitive Strengths & Weaknesses
9.13 LOTTE BIOLOGICS Co., Ltd.
9.13.1 LOTTE BIOLOGICS Co., Ltd. Details
9.13.2 LOTTE BIOLOGICS Co., Ltd. Major Business
9.13.3 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.13.4 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 LOTTE BIOLOGICS Co., Ltd. Recent Developments/Updates
9.13.6 LOTTE BIOLOGICS Co., Ltd. Competitive Strengths & Weaknesses
9.14 Pfizer CentreOne
9.14.1 Pfizer CentreOne Details
9.14.2 Pfizer CentreOne Major Business
9.14.3 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.14.4 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Pfizer CentreOne Recent Developments/Updates
9.14.6 Pfizer CentreOne Competitive Strengths & Weaknesses
9.15 AbbVie Contract Manufacturing
9.15.1 AbbVie Contract Manufacturing Details
9.15.2 AbbVie Contract Manufacturing Major Business
9.15.3 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.15.4 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 AbbVie Contract Manufacturing Recent Developments/Updates
9.15.6 AbbVie Contract Manufacturing Competitive Strengths & Weaknesses
9.16 Syngene International Limited
9.16.1 Syngene International Limited Details
9.16.2 Syngene International Limited Major Business
9.16.3 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.16.4 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Syngene International Limited Recent Developments/Updates
9.16.6 Syngene International Limited Competitive Strengths & Weaknesses
9.17 Avid Bioservices, Inc.
9.17.1 Avid Bioservices, Inc. Details
9.17.2 Avid Bioservices, Inc. Major Business
9.17.3 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.17.4 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Avid Bioservices, Inc. Recent Developments/Updates
9.17.6 Avid Bioservices, Inc. Competitive Strengths & Weaknesses
9.18 Recipharm Advanced Bio
9.18.1 Recipharm Advanced Bio Details
9.18.2 Recipharm Advanced Bio Major Business
9.18.3 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.18.4 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Recipharm Advanced Bio Recent Developments/Updates
9.18.6 Recipharm Advanced Bio Competitive Strengths & Weaknesses
9.19 Ajinomoto Bio-Pharma Services
9.19.1 Ajinomoto Bio-Pharma Services Details
9.19.2 Ajinomoto Bio-Pharma Services Major Business
9.19.3 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.19.4 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Ajinomoto Bio-Pharma Services Recent Developments/Updates
9.19.6 Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
9.20 Wacker Biotech GmbH
9.20.1 Wacker Biotech GmbH Details
9.20.2 Wacker Biotech GmbH Major Business
9.20.3 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.20.4 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Wacker Biotech GmbH Recent Developments/Updates
9.20.6 Wacker Biotech GmbH Competitive Strengths & Weaknesses
9.21 Bora Biologics
9.21.1 Bora Biologics Details
9.21.2 Bora Biologics Major Business
9.21.3 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.21.4 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Bora Biologics Recent Developments/Updates
9.21.6 Bora Biologics Competitive Strengths & Weaknesses
9.22 3PBIOVIAN
9.22.1 3PBIOVIAN Details
9.22.2 3PBIOVIAN Major Business
9.22.3 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.22.4 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 3PBIOVIAN Recent Developments/Updates
9.22.6 3PBIOVIAN Competitive Strengths & Weaknesses
9.23 Fareva
9.23.1 Fareva Details
9.23.2 Fareva Major Business
9.23.3 Fareva Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.23.4 Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Fareva Recent Developments/Updates
9.23.6 Fareva Competitive Strengths & Weaknesses
9.24 Aenova Group
9.24.1 Aenova Group Details
9.24.2 Aenova Group Major Business
9.24.3 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.24.4 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Aenova Group Recent Developments/Updates
9.24.6 Aenova Group Competitive Strengths & Weaknesses
9.25 Siegfried Holding AG
9.25.1 Siegfried Holding AG Details
9.25.2 Siegfried Holding AG Major Business
9.25.3 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.25.4 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Siegfried Holding AG Recent Developments/Updates
9.25.6 Siegfried Holding AG Competitive Strengths & Weaknesses
9.26 GenScript ProBio
9.26.1 GenScript ProBio Details
9.26.2 GenScript ProBio Major Business
9.26.3 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.26.4 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 GenScript ProBio Recent Developments/Updates
9.26.6 GenScript ProBio Competitive Strengths & Weaknesses
9.27 Chime Biologics (Wuhan) Co., Ltd.
9.27.1 Chime Biologics (Wuhan) Co., Ltd. Details
9.27.2 Chime Biologics (Wuhan) Co., Ltd. Major Business
9.27.3 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.27.4 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Chime Biologics (Wuhan) Co., Ltd. Recent Developments/Updates
9.27.6 Chime Biologics (Wuhan) Co., Ltd. Competitive Strengths & Weaknesses
9.28 MabPlex International
9.28.1 MabPlex International Details
9.28.2 MabPlex International Major Business
9.28.3 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.28.4 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 MabPlex International Recent Developments/Updates
9.28.6 MabPlex International Competitive Strengths & Weaknesses
9.29 Pharmaron Beijing Co., Ltd.
9.29.1 Pharmaron Beijing Co., Ltd. Details
9.29.2 Pharmaron Beijing Co., Ltd. Major Business
9.29.3 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.29.4 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Pharmaron Beijing Co., Ltd. Recent Developments/Updates
9.29.6 Pharmaron Beijing Co., Ltd. Competitive Strengths & Weaknesses
9.30 Thousand Oaks Biologics Inc.
9.30.1 Thousand Oaks Biologics Inc. Details
9.30.2 Thousand Oaks Biologics Inc. Major Business
9.30.3 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.30.4 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Thousand Oaks Biologics Inc. Recent Developments/Updates
9.30.6 Thousand Oaks Biologics Inc. Competitive Strengths & Weaknesses
9.31 Cytovance Biologics, Inc.
9.31.1 Cytovance Biologics, Inc. Details
9.31.2 Cytovance Biologics, Inc. Major Business
9.31.3 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.31.4 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Cytovance Biologics, Inc. Recent Developments/Updates
9.31.6 Cytovance Biologics, Inc. Competitive Strengths & Weaknesses
9.32 Porton Pharma Solutions Ltd.
9.32.1 Porton Pharma Solutions Ltd. Details
9.32.2 Porton Pharma Solutions Ltd. Major Business
9.32.3 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
9.32.4 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Porton Pharma Solutions Ltd. Recent Developments/Updates
9.32.6 Porton Pharma Solutions Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Biologics CMO (Contract Manufacturing Organization) Services Industry Chain
10.2 Biologics CMO (Contract Manufacturing Organization) Services Upstream Analysis
10.3 Biologics CMO (Contract Manufacturing Organization) Services Midstream Analysis
10.4 Biologics CMO (Contract Manufacturing Organization) Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Biologics CMO (Contract Manufacturing Organization) Services Players in 2025
Table 12. World Biologics CMO (Contract Manufacturing Organization) Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Biologics CMO (Contract Manufacturing Organization) Services Company Evaluation Quadrant
Table 14. Head Office of Key Biologics CMO (Contract Manufacturing Organization) Services Players
Table 15. Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Type Footprint
Table 16. Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Application Footprint
Table 17. Biologics CMO (Contract Manufacturing Organization) Services Mergers & Acquisitions Activity
Table 18. United States VS China Biologics CMO (Contract Manufacturing Organization) Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share (2021-2026)
Table 23. China Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share (2021-2026)
Table 29. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Value by CMO Provider Type (2021-2026) & (USD Million)
Table 34. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type (2027-2032) & (USD Million)
Table 35. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage, (USD Million), 2021 & 2025 & 2032
Table 36. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Value by Manufacturing Stage (2021-2026) & (USD Million)
Table 37. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage (2027-2032) & (USD Million)
Table 38. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Lonza Group AG Basic Information, Manufacturing Base and Competitors
Table 42. Lonza Group AG Major Business
Table 43. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 44. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Lonza Group AG Recent Developments/Updates
Table 46. Lonza Group AG Competitive Strengths & Weaknesses
Table 47. Samsung Biologics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. Samsung Biologics Co., Ltd. Major Business
Table 49. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 50. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Samsung Biologics Co., Ltd. Recent Developments/Updates
Table 52. Samsung Biologics Co., Ltd. Competitive Strengths & Weaknesses
Table 53. FUJIFILM Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 54. FUJIFILM Biotechnologies Major Business
Table 55. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 56. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. FUJIFILM Biotechnologies Recent Developments/Updates
Table 58. FUJIFILM Biotechnologies Competitive Strengths & Weaknesses
Table 59. Boehringer Ingelheim BioXcellence Basic Information, Manufacturing Base and Competitors
Table 60. Boehringer Ingelheim BioXcellence Major Business
Table 61. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 62. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Boehringer Ingelheim BioXcellence Recent Developments/Updates
Table 64. Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
Table 65. WuXi Biologics (Cayman) Inc. Basic Information, Manufacturing Base and Competitors
Table 66. WuXi Biologics (Cayman) Inc. Major Business
Table 67. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 68. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. WuXi Biologics (Cayman) Inc. Recent Developments/Updates
Table 70. WuXi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific – Patheon Pharma Services Basic Information, Manufacturing Base and Competitors
Table 72. Thermo Fisher Scientific – Patheon Pharma Services Major Business
Table 73. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 74. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Thermo Fisher Scientific – Patheon Pharma Services Recent Developments/Updates
Table 76. Thermo Fisher Scientific – Patheon Pharma Services Competitive Strengths & Weaknesses
Table 77. Catalent, Inc. Basic Information, Manufacturing Base and Competitors
Table 78. Catalent, Inc. Major Business
Table 79. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 80. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent, Inc. Recent Developments/Updates
Table 82. Catalent, Inc. Competitive Strengths & Weaknesses
Table 83. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 84. AGC Biologics Major Business
Table 85. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 86. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. AGC Biologics Recent Developments/Updates
Table 88. AGC Biologics Competitive Strengths & Weaknesses
Table 89. National Resilience, Inc. Basic Information, Manufacturing Base and Competitors
Table 90. National Resilience, Inc. Major Business
Table 91. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 92. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. National Resilience, Inc. Recent Developments/Updates
Table 94. National Resilience, Inc. Competitive Strengths & Weaknesses
Table 95. Vetter Pharma International GmbH Basic Information, Manufacturing Base and Competitors
Table 96. Vetter Pharma International GmbH Major Business
Table 97. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 98. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Vetter Pharma International GmbH Recent Developments/Updates
Table 100. Vetter Pharma International GmbH Competitive Strengths & Weaknesses
Table 101. Rentschler Biopharma SE Basic Information, Manufacturing Base and Competitors
Table 102. Rentschler Biopharma SE Major Business
Table 103. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 104. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Rentschler Biopharma SE Recent Developments/Updates
Table 106. Rentschler Biopharma SE Competitive Strengths & Weaknesses
Table 107. KBI Biopharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 108. KBI Biopharma, Inc. Major Business
Table 109. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 110. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. KBI Biopharma, Inc. Recent Developments/Updates
Table 112. KBI Biopharma, Inc. Competitive Strengths & Weaknesses
Table 113. LOTTE BIOLOGICS Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 114. LOTTE BIOLOGICS Co., Ltd. Major Business
Table 115. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 116. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. LOTTE BIOLOGICS Co., Ltd. Recent Developments/Updates
Table 118. LOTTE BIOLOGICS Co., Ltd. Competitive Strengths & Weaknesses
Table 119. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 120. Pfizer CentreOne Major Business
Table 121. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 122. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Pfizer CentreOne Recent Developments/Updates
Table 124. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 125. AbbVie Contract Manufacturing Basic Information, Manufacturing Base and Competitors
Table 126. AbbVie Contract Manufacturing Major Business
Table 127. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 128. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. AbbVie Contract Manufacturing Recent Developments/Updates
Table 130. AbbVie Contract Manufacturing Competitive Strengths & Weaknesses
Table 131. Syngene International Limited Basic Information, Manufacturing Base and Competitors
Table 132. Syngene International Limited Major Business
Table 133. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 134. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Syngene International Limited Recent Developments/Updates
Table 136. Syngene International Limited Competitive Strengths & Weaknesses
Table 137. Avid Bioservices, Inc. Basic Information, Manufacturing Base and Competitors
Table 138. Avid Bioservices, Inc. Major Business
Table 139. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 140. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Avid Bioservices, Inc. Recent Developments/Updates
Table 142. Avid Bioservices, Inc. Competitive Strengths & Weaknesses
Table 143. Recipharm Advanced Bio Basic Information, Manufacturing Base and Competitors
Table 144. Recipharm Advanced Bio Major Business
Table 145. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 146. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Recipharm Advanced Bio Recent Developments/Updates
Table 148. Recipharm Advanced Bio Competitive Strengths & Weaknesses
Table 149. Ajinomoto Bio-Pharma Services Basic Information, Manufacturing Base and Competitors
Table 150. Ajinomoto Bio-Pharma Services Major Business
Table 151. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 152. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Ajinomoto Bio-Pharma Services Recent Developments/Updates
Table 154. Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
Table 155. Wacker Biotech GmbH Basic Information, Manufacturing Base and Competitors
Table 156. Wacker Biotech GmbH Major Business
Table 157. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 158. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Wacker Biotech GmbH Recent Developments/Updates
Table 160. Wacker Biotech GmbH Competitive Strengths & Weaknesses
Table 161. Bora Biologics Basic Information, Manufacturing Base and Competitors
Table 162. Bora Biologics Major Business
Table 163. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 164. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Bora Biologics Recent Developments/Updates
Table 166. Bora Biologics Competitive Strengths & Weaknesses
Table 167. 3PBIOVIAN Basic Information, Manufacturing Base and Competitors
Table 168. 3PBIOVIAN Major Business
Table 169. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 170. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. 3PBIOVIAN Recent Developments/Updates
Table 172. 3PBIOVIAN Competitive Strengths & Weaknesses
Table 173. Fareva Basic Information, Manufacturing Base and Competitors
Table 174. Fareva Major Business
Table 175. Fareva Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 176. Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Fareva Recent Developments/Updates
Table 178. Fareva Competitive Strengths & Weaknesses
Table 179. Aenova Group Basic Information, Manufacturing Base and Competitors
Table 180. Aenova Group Major Business
Table 181. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 182. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Aenova Group Recent Developments/Updates
Table 184. Aenova Group Competitive Strengths & Weaknesses
Table 185. Siegfried Holding AG Basic Information, Manufacturing Base and Competitors
Table 186. Siegfried Holding AG Major Business
Table 187. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 188. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Siegfried Holding AG Recent Developments/Updates
Table 190. Siegfried Holding AG Competitive Strengths & Weaknesses
Table 191. GenScript ProBio Basic Information, Manufacturing Base and Competitors
Table 192. GenScript ProBio Major Business
Table 193. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 194. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. GenScript ProBio Recent Developments/Updates
Table 196. GenScript ProBio Competitive Strengths & Weaknesses
Table 197. Chime Biologics (Wuhan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 198. Chime Biologics (Wuhan) Co., Ltd. Major Business
Table 199. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 200. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Chime Biologics (Wuhan) Co., Ltd. Recent Developments/Updates
Table 202. Chime Biologics (Wuhan) Co., Ltd. Competitive Strengths & Weaknesses
Table 203. MabPlex International Basic Information, Manufacturing Base and Competitors
Table 204. MabPlex International Major Business
Table 205. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 206. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. MabPlex International Recent Developments/Updates
Table 208. MabPlex International Competitive Strengths & Weaknesses
Table 209. Pharmaron Beijing Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 210. Pharmaron Beijing Co., Ltd. Major Business
Table 211. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 212. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Pharmaron Beijing Co., Ltd. Recent Developments/Updates
Table 214. Pharmaron Beijing Co., Ltd. Competitive Strengths & Weaknesses
Table 215. Thousand Oaks Biologics Inc. Basic Information, Manufacturing Base and Competitors
Table 216. Thousand Oaks Biologics Inc. Major Business
Table 217. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 218. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Thousand Oaks Biologics Inc. Recent Developments/Updates
Table 220. Thousand Oaks Biologics Inc. Competitive Strengths & Weaknesses
Table 221. Cytovance Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 222. Cytovance Biologics, Inc. Major Business
Table 223. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 224. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Cytovance Biologics, Inc. Recent Developments/Updates
Table 226. Cytovance Biologics, Inc. Competitive Strengths & Weaknesses
Table 227. Porton Pharma Solutions Ltd. Basic Information, Manufacturing Base and Competitors
Table 228. Porton Pharma Solutions Ltd. Major Business
Table 229. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 230. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Porton Pharma Solutions Ltd. Recent Developments/Updates
Table 232. Porton Pharma Solutions Ltd. Competitive Strengths & Weaknesses
Table 233. Global Key Players of Biologics CMO (Contract Manufacturing Organization) Services Upstream (Raw Materials)
Table 234. Global Biologics CMO (Contract Manufacturing Organization) Services Typical Customers
Table 1. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Biologics CMO (Contract Manufacturing Organization) Services Players in 2025
Table 12. World Biologics CMO (Contract Manufacturing Organization) Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Biologics CMO (Contract Manufacturing Organization) Services Company Evaluation Quadrant
Table 14. Head Office of Key Biologics CMO (Contract Manufacturing Organization) Services Players
Table 15. Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Type Footprint
Table 16. Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Application Footprint
Table 17. Biologics CMO (Contract Manufacturing Organization) Services Mergers & Acquisitions Activity
Table 18. United States VS China Biologics CMO (Contract Manufacturing Organization) Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share (2021-2026)
Table 23. China Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Biologics CMO (Contract Manufacturing Organization) Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share (2021-2026)
Table 29. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Value by CMO Provider Type (2021-2026) & (USD Million)
Table 34. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type (2027-2032) & (USD Million)
Table 35. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage, (USD Million), 2021 & 2025 & 2032
Table 36. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Value by Manufacturing Stage (2021-2026) & (USD Million)
Table 37. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage (2027-2032) & (USD Million)
Table 38. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Lonza Group AG Basic Information, Manufacturing Base and Competitors
Table 42. Lonza Group AG Major Business
Table 43. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 44. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Lonza Group AG Recent Developments/Updates
Table 46. Lonza Group AG Competitive Strengths & Weaknesses
Table 47. Samsung Biologics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. Samsung Biologics Co., Ltd. Major Business
Table 49. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 50. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Samsung Biologics Co., Ltd. Recent Developments/Updates
Table 52. Samsung Biologics Co., Ltd. Competitive Strengths & Weaknesses
Table 53. FUJIFILM Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 54. FUJIFILM Biotechnologies Major Business
Table 55. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 56. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. FUJIFILM Biotechnologies Recent Developments/Updates
Table 58. FUJIFILM Biotechnologies Competitive Strengths & Weaknesses
Table 59. Boehringer Ingelheim BioXcellence Basic Information, Manufacturing Base and Competitors
Table 60. Boehringer Ingelheim BioXcellence Major Business
Table 61. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 62. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Boehringer Ingelheim BioXcellence Recent Developments/Updates
Table 64. Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
Table 65. WuXi Biologics (Cayman) Inc. Basic Information, Manufacturing Base and Competitors
Table 66. WuXi Biologics (Cayman) Inc. Major Business
Table 67. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 68. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. WuXi Biologics (Cayman) Inc. Recent Developments/Updates
Table 70. WuXi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific – Patheon Pharma Services Basic Information, Manufacturing Base and Competitors
Table 72. Thermo Fisher Scientific – Patheon Pharma Services Major Business
Table 73. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 74. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Thermo Fisher Scientific – Patheon Pharma Services Recent Developments/Updates
Table 76. Thermo Fisher Scientific – Patheon Pharma Services Competitive Strengths & Weaknesses
Table 77. Catalent, Inc. Basic Information, Manufacturing Base and Competitors
Table 78. Catalent, Inc. Major Business
Table 79. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 80. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent, Inc. Recent Developments/Updates
Table 82. Catalent, Inc. Competitive Strengths & Weaknesses
Table 83. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 84. AGC Biologics Major Business
Table 85. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 86. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. AGC Biologics Recent Developments/Updates
Table 88. AGC Biologics Competitive Strengths & Weaknesses
Table 89. National Resilience, Inc. Basic Information, Manufacturing Base and Competitors
Table 90. National Resilience, Inc. Major Business
Table 91. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 92. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. National Resilience, Inc. Recent Developments/Updates
Table 94. National Resilience, Inc. Competitive Strengths & Weaknesses
Table 95. Vetter Pharma International GmbH Basic Information, Manufacturing Base and Competitors
Table 96. Vetter Pharma International GmbH Major Business
Table 97. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 98. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Vetter Pharma International GmbH Recent Developments/Updates
Table 100. Vetter Pharma International GmbH Competitive Strengths & Weaknesses
Table 101. Rentschler Biopharma SE Basic Information, Manufacturing Base and Competitors
Table 102. Rentschler Biopharma SE Major Business
Table 103. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 104. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Rentschler Biopharma SE Recent Developments/Updates
Table 106. Rentschler Biopharma SE Competitive Strengths & Weaknesses
Table 107. KBI Biopharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 108. KBI Biopharma, Inc. Major Business
Table 109. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 110. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. KBI Biopharma, Inc. Recent Developments/Updates
Table 112. KBI Biopharma, Inc. Competitive Strengths & Weaknesses
Table 113. LOTTE BIOLOGICS Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 114. LOTTE BIOLOGICS Co., Ltd. Major Business
Table 115. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 116. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. LOTTE BIOLOGICS Co., Ltd. Recent Developments/Updates
Table 118. LOTTE BIOLOGICS Co., Ltd. Competitive Strengths & Weaknesses
Table 119. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 120. Pfizer CentreOne Major Business
Table 121. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 122. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Pfizer CentreOne Recent Developments/Updates
Table 124. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 125. AbbVie Contract Manufacturing Basic Information, Manufacturing Base and Competitors
Table 126. AbbVie Contract Manufacturing Major Business
Table 127. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 128. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. AbbVie Contract Manufacturing Recent Developments/Updates
Table 130. AbbVie Contract Manufacturing Competitive Strengths & Weaknesses
Table 131. Syngene International Limited Basic Information, Manufacturing Base and Competitors
Table 132. Syngene International Limited Major Business
Table 133. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 134. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Syngene International Limited Recent Developments/Updates
Table 136. Syngene International Limited Competitive Strengths & Weaknesses
Table 137. Avid Bioservices, Inc. Basic Information, Manufacturing Base and Competitors
Table 138. Avid Bioservices, Inc. Major Business
Table 139. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 140. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Avid Bioservices, Inc. Recent Developments/Updates
Table 142. Avid Bioservices, Inc. Competitive Strengths & Weaknesses
Table 143. Recipharm Advanced Bio Basic Information, Manufacturing Base and Competitors
Table 144. Recipharm Advanced Bio Major Business
Table 145. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 146. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Recipharm Advanced Bio Recent Developments/Updates
Table 148. Recipharm Advanced Bio Competitive Strengths & Weaknesses
Table 149. Ajinomoto Bio-Pharma Services Basic Information, Manufacturing Base and Competitors
Table 150. Ajinomoto Bio-Pharma Services Major Business
Table 151. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 152. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Ajinomoto Bio-Pharma Services Recent Developments/Updates
Table 154. Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
Table 155. Wacker Biotech GmbH Basic Information, Manufacturing Base and Competitors
Table 156. Wacker Biotech GmbH Major Business
Table 157. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 158. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Wacker Biotech GmbH Recent Developments/Updates
Table 160. Wacker Biotech GmbH Competitive Strengths & Weaknesses
Table 161. Bora Biologics Basic Information, Manufacturing Base and Competitors
Table 162. Bora Biologics Major Business
Table 163. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 164. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Bora Biologics Recent Developments/Updates
Table 166. Bora Biologics Competitive Strengths & Weaknesses
Table 167. 3PBIOVIAN Basic Information, Manufacturing Base and Competitors
Table 168. 3PBIOVIAN Major Business
Table 169. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 170. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. 3PBIOVIAN Recent Developments/Updates
Table 172. 3PBIOVIAN Competitive Strengths & Weaknesses
Table 173. Fareva Basic Information, Manufacturing Base and Competitors
Table 174. Fareva Major Business
Table 175. Fareva Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 176. Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Fareva Recent Developments/Updates
Table 178. Fareva Competitive Strengths & Weaknesses
Table 179. Aenova Group Basic Information, Manufacturing Base and Competitors
Table 180. Aenova Group Major Business
Table 181. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 182. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Aenova Group Recent Developments/Updates
Table 184. Aenova Group Competitive Strengths & Weaknesses
Table 185. Siegfried Holding AG Basic Information, Manufacturing Base and Competitors
Table 186. Siegfried Holding AG Major Business
Table 187. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 188. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Siegfried Holding AG Recent Developments/Updates
Table 190. Siegfried Holding AG Competitive Strengths & Weaknesses
Table 191. GenScript ProBio Basic Information, Manufacturing Base and Competitors
Table 192. GenScript ProBio Major Business
Table 193. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 194. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. GenScript ProBio Recent Developments/Updates
Table 196. GenScript ProBio Competitive Strengths & Weaknesses
Table 197. Chime Biologics (Wuhan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 198. Chime Biologics (Wuhan) Co., Ltd. Major Business
Table 199. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 200. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Chime Biologics (Wuhan) Co., Ltd. Recent Developments/Updates
Table 202. Chime Biologics (Wuhan) Co., Ltd. Competitive Strengths & Weaknesses
Table 203. MabPlex International Basic Information, Manufacturing Base and Competitors
Table 204. MabPlex International Major Business
Table 205. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 206. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. MabPlex International Recent Developments/Updates
Table 208. MabPlex International Competitive Strengths & Weaknesses
Table 209. Pharmaron Beijing Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 210. Pharmaron Beijing Co., Ltd. Major Business
Table 211. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 212. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Pharmaron Beijing Co., Ltd. Recent Developments/Updates
Table 214. Pharmaron Beijing Co., Ltd. Competitive Strengths & Weaknesses
Table 215. Thousand Oaks Biologics Inc. Basic Information, Manufacturing Base and Competitors
Table 216. Thousand Oaks Biologics Inc. Major Business
Table 217. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 218. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Thousand Oaks Biologics Inc. Recent Developments/Updates
Table 220. Thousand Oaks Biologics Inc. Competitive Strengths & Weaknesses
Table 221. Cytovance Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 222. Cytovance Biologics, Inc. Major Business
Table 223. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 224. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Cytovance Biologics, Inc. Recent Developments/Updates
Table 226. Cytovance Biologics, Inc. Competitive Strengths & Weaknesses
Table 227. Porton Pharma Solutions Ltd. Basic Information, Manufacturing Base and Competitors
Table 228. Porton Pharma Solutions Ltd. Major Business
Table 229. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Services
Table 230. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Porton Pharma Solutions Ltd. Recent Developments/Updates
Table 232. Porton Pharma Solutions Ltd. Competitive Strengths & Weaknesses
Table 233. Global Key Players of Biologics CMO (Contract Manufacturing Organization) Services Upstream (Raw Materials)
Table 234. Global Biologics CMO (Contract Manufacturing Organization) Services Typical Customers
LIST OF FIGURES
Figure 1. Biologics CMO (Contract Manufacturing Organization) Services Picture
Figure 2. World Biologics CMO (Contract Manufacturing Organization) Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biologics CMO (Contract Manufacturing Organization) Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 13. Biologics CMO (Contract Manufacturing Organization) Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Biologics CMO (Contract Manufacturing Organization) Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biologics CMO (Contract Manufacturing Organization) Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biologics CMO (Contract Manufacturing Organization) Services Markets in 2025
Figure 27. United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type in 2025
Figure 31. Cell and Gene Therapies
Figure 32. Antibodies
Figure 33. Vaccines
Figure 34. Others
Figure 35. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2021-2032)
Figure 36. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type in 2025
Figure 38. In-house CMO
Figure 39. Independent CMO
Figure 40. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type (2021-2032)
Figure 41. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage, (USD Million), 2021 & 2025 & 2032
Figure 42. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage in 2025
Figure 43. Drug Substance (DS) Manufacturing
Figure 44. Drug Product (DP) Manufacturing
Figure 45. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage (2021-2032)
Figure 46. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application in 2025
Figure 48. Large Pharmaceutical and Biopharmaceutical Companies
Figure 49. Small and Mid-sized Pharmaceutical and Biotechnology Companies
Figure 50. Others
Figure 51. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2032)
Figure 52. Biologics CMO (Contract Manufacturing Organization) Services Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Biologics CMO (Contract Manufacturing Organization) Services Picture
Figure 2. World Biologics CMO (Contract Manufacturing Organization) Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biologics CMO (Contract Manufacturing Organization) Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Biologics CMO (Contract Manufacturing Organization) Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Biologics CMO (Contract Manufacturing Organization) Services Revenue (2021-2032) & (USD Million)
Figure 13. Biologics CMO (Contract Manufacturing Organization) Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Biologics CMO (Contract Manufacturing Organization) Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biologics CMO (Contract Manufacturing Organization) Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biologics CMO (Contract Manufacturing Organization) Services Markets in 2025
Figure 27. United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type in 2025
Figure 31. Cell and Gene Therapies
Figure 32. Antibodies
Figure 33. Vaccines
Figure 34. Others
Figure 35. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2021-2032)
Figure 36. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type in 2025
Figure 38. In-house CMO
Figure 39. Independent CMO
Figure 40. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type (2021-2032)
Figure 41. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage, (USD Million), 2021 & 2025 & 2032
Figure 42. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage in 2025
Figure 43. Drug Substance (DS) Manufacturing
Figure 44. Drug Product (DP) Manufacturing
Figure 45. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage (2021-2032)
Figure 46. World Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application in 2025
Figure 48. Large Pharmaceutical and Biopharmaceutical Companies
Figure 49. Small and Mid-sized Pharmaceutical and Biotechnology Companies
Figure 50. Others
Figure 51. World Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2032)
Figure 52. Biologics CMO (Contract Manufacturing Organization) Services Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
